ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0032570;response to progesterone;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;105.99106082751567;6.166155715036245;0.0035474254201351726;0.6384578026126634;[YAP1, GABRB1, TGFB2, TGFB1, CAV1, PTGER2, FOS, THBS1, CLDN4, FOSB, CD38, TLR2]
GO:0032691;negative regulation of interleukin-1 beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;6.781341354126479;0.002875903446815721;0.6977174774718518;[GHSR, NLRP3, TNFAIP3, ARRB2, PML]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, IL18, ACTN4, GREM1, IL23A, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, NOD2, CCL19, CD14, TNFSF14, TNFRSF10B, EIF2AK2, NLRP12, CD27, IL18R1]
GO:1900016;negative regulation of cytokine production involved in inflammatory response;8.0;1.0;0.875;9.628524252492122;227.00494280179373;7.379178354882098;0.007597651144391222;0.7523715242355574;[IL1R2, NLRC3]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, PYCARD, TNFSF11, TRIM25, PRKCH, BTK, PRKCQ, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, PRKCZ, NLRP3, S100A12, TGFB1, EIF2AK2, NFKB1, NFKB2, MYD88, CD40, ITGB2, CD36, CHUK, IL18, IRAK3, TRAF1, GREM1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, ETS1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, IL10, PPP1R16B, GHSR, ANXA1, ANXA3, GAB1, CYBB, SIRT1, F3, GREM1, IL1A, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, C3, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0051090;regulation of DNA binding transcription factor activity;10.0;0.7192862368539868;0.7748841302879137;9.223059144383958;255.33763090554476;3.793137346993279;0.00854592071745993;0.6092222321850824;[PHB2, AKT1, TNFSF11, CYP1B1, TRIM25, PRKCH, SFRP4, BTK, SIK1, PRKCQ, TRIB1, BEX1, TWIST1, PRKCZ, PKHD1, NHLH2, S100A12, HMOX1, FZD1, JUN, JUP, EIF2AK2, ID1, EZH2, CD40, CD36, HAVCR2, IL10, EDN1, SYK, ANXA3, NFAM1, IL18, FOS, SIRT1, PSMA6, HCK, IL1B, KIT, TLR6, SGK1, TLR4, TLR2, SP100, FLNA, NR1H4, POU4F1, NLRP12, CD40LG, FOXA2, CSF3, TNF, CLU, PYCARD, MEN1, FANCD2, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, NLRP3, TGFB1, WFS1, NFKB1, NFKB2, NFKBIA, IL6, COPS5, JMY, CCDC22, MYD88, CREBZF, ITGB2, TNFAIP3, ARRB1, ARRB2, MYOCD, CHUK, DDX58, IRAK3, TRAF1, GREM1, XCL1, LTF, NLRC3, NLRC4, NOD2, KLF4]
GO:0000188;inactivation of MAPK activity;13.0;0.8436909121759173;0.8844004208555951;9.558319993818873;2610.871803759405;6.518977089658987;0.08738352963975493;0.7959357562962344;[DUSP2, DUSP3, DUSP1, CAV1, DUSP6, DUSP10, PPP2R1A]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, ARRB1, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0050796;regulation of insulin secretion;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;205.48125160941495;4.61801832846594;0.006877272570246766;0.6324062972578516;[KCNG2, SLC2A2, ARRB1, TNF, HNF4A, CD38, FAM3D, SOX4, GHSR, PRKCE, IFNG, IL1B, CFTR, BLK, KCNA5, ITPR3, DPP4, TMEM27, CNR1, CCL5, NR1H4, FKBP1B, FOXA2]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[IHH, EDNRA, PDGFRA, TPM1, MSH2, TWIST1, GATA3, GATA1, EPB41L5, CCNB2, CCNB1, PLCG1, MYH10, STIL, EIF2S2, BMP2, MAFF, BCL2L1, PTPRR, TMEM100, HHEX, EDN1, DUSP3, RXRA, TIE1]
GO:0030949;positive regulation of vascular endothelial growth factor receptor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;213.0397923327438;7.069023426578259;0.0071302501260115695;0.7124295520356204;[IL1B, ITGB3]
GO:0070164;negative regulation of adiponectin secretion;9.0;1.0;0.896240625180289;9.628524252492122;854.5051635618736;8.390779266560578;0.028599518819696718;0.8253454670833372;[IL1B]
GO:0034620;cellular response to unfolded protein;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;123.17901887317109;6.8867018697843045;0.004122690907765296;0.6753065664753021;[HSPA6]
GO:0060355;positive regulation of cell adhesion molecule production;5.0;1.0;0.7902410118609202;9.628524252492122;40.679961272662325;8.390779266560578;0.0013615216942077584;0.7193458537639684;[COLEC12, CAV1, IL1B]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, RIN2, IQGAP3, RASGRP1, RASGRP4, HMOX1, JUN, HACE1, PLK2, DHCR24, ARHGAP30, COL1A2, BCL6, RGL4, RGL1, LAT, DOCK5, CDKN1A, DOCK4, ARHGAP6, ARHGAP4, RAC2, RALGPS2, ARHGEF12, CHUK, RHOG, RHOH, VAV1, RAB33B, CCNA2, RHOU, AIF1, RAB21, PAK1, PDPN, EPS8L1, EPS8L3, DNAJA3]
GO:0045410;positive regulation of interleukin-6 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.3044735649636;7.8311634786251565;0.02792341990494083;0.7754860644832351;[TLR1, IL1B, PTAFR, TLR6, EREG]
GO:0033092;positive regulation of immature T cell proliferation in thymus;11.0;1.0;0.9324289523296623;9.628524252492122;1868.4618253278568;8.67846133901236;0.06253573578725322;0.8762458687964789;[IL1B]
GO:0046627;negative regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;294.34753946768484;6.311337724880743;0.009851547250396369;0.6736814700148209;[PID1, CISH, PRKCD, TSC2, SLA2, PRKCZ, SOCS2, PTPRE, IL1B, PRKCQ]
GO:0051412;response to corticosterone;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;159.4387911184404;6.7325511899570465;0.0053362728531380675;0.719302980950052;[CDKN1A, FOSB, AVPR1A, FOS]
GO:2000484;positive regulation of interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.069023426578259;0.02521906460756386;0.7767511986393403;[FCN1, F2R, TLR1, CD2, PYCARD, FFAR2, CD58, CD14, CD244, TLR2]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[NCF1, TNFAIP3, PTPRK, ETS1, AQP1, IL18RAP, MYB, AKT1, CYP1B1, PDGFRA, ANXA1, CHUK, ARG1, TPM1, PRKCD, FOS, MMP9, SIRT1, PAX2, DNM2, CCNA2, BTK, PCNA, FOXO1, CST3, PDGFD, ECT2, JUN, KLF4, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CSF3, CD80, PIK3CD, ARRB2, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, IGFBP5, GAB1, IL18, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, ADAM8, HBEGF, ENG, PDGFA, GATA3, THBS1, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[TSC2, ARRB2, KLF4, SIRT1, PKHD1, BANK1, AKT1, EPHA2]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, AIF1, KLRK1, AKT1, CD36, EDN1, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0035025;positive regulation of Rho protein signal transduction;10.0;1.0;0.9152410118609203;9.628524252492122;339.6245583269611;6.481236761676141;0.01136692832494487;0.7466917612613706;[PDGFRB, GPR35, F2R, ARRB1, COL3A1, GPR18, F2RL3]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, GAB2, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, SECTM1, FASLG, NUP62, CCR7, CD36, CHUK, ZDHHC17, IL1B, TLR6, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, LTBR]
GO:0045665;negative regulation of neuron differentiation;8.0;0.6162540371078848;0.6831270185539424;8.732436227935485;338.1488864638422;4.401795219996305;0.011317538915704735;0.6001080122550225;[SEMA5B, EDNRB, LGALS1, ARHGDIA, TNR, HOXA2, EPHB2, MED1, SEMA6A, PAQR3, THY1, JAG1, PLK2, PTK2, ID1, ITM2C, NRP1, LRRK2, CTSZ, ARHGAP4, CD38, YWHAH, DCC, RGMA, IL1B, NLGN1, LRP1, DLL1, SPP1, LINGO1, SEMA4B, IRX3, MEIS1, PMP22]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[TNF, PYCARD, CYP1B1, IL6R, DAPK1, PRKCD, MSH6, MELK, MSH2, IFI27, LGALS12, BTK, EPHA2, CUL5, LY96, TNFRSF11A, TP53BP2, HMOX1, SFN, CD14, TGFB2, TGFB1, TNFSF12, CAV1, TNFRSF10C, TNFRSF10B, INHBA, JMY, BCL3, CD28, BCL2, CD27, CD24, BCL2L1, CDKN1A, CD40, FASLG, BRCA1, BRCA2, CD3E, CD38, DCC, PAWR, TNFRSF1B, SIRT1, IL1A, IFNG, IL1B, TLR4, PPP1R15A, CEBPB, BCL2A1, IFI6, PERP, E2F1, E2F2, CASP8AP2, IL33, SORT1, G0S2, GZMB, MLH1, POU4F1, PML, GZMH, CD5]
GO:0097192;extrinsic apoptotic signaling pathway in absence of ligand;7.0;1.0;0.8509193652572005;9.628524252492122;76.30875120206336;6.375876246018314;0.0025539852293156346;0.6769819729871445;[BCL2A1, DCC, IL1A, IL1B, BCL2, BCL2L1]
GO:0032308;positive regulation of prostaglandin secretion;10.0;0.8933024483968273;0.861892236059334;9.548481544818586;484.66648287468473;7.474488534686424;0.016221351010299763;0.7974867031240476;[EDN1, IL1B, TNFSF11, TNFRSF11A, MIF, MAP2K6]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[IL5RA, TNF, FGF5, TNFSF11, MEN1, PDGFRB, MEF2A, PDGFRA, MED1, MEF2C, MAP2K2, PAQR3, EREG, BTC, TRIB1, PDGFA, CSF2RB, IQGAP3, CSF2RA, RASGRP1, RASGRP4, SPTA1, MAP2K6, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, JAK3, MAP4K1, CHUK, STRADB, IL18, GFRA3, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, MAPK13, KITLG, IL2RB, TEK]
GO:0043491;protein kinase B signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.250713103064308;8.845336528452411E-4;0.6427820713687392;[CD40, TGFB1, TSC2, TNF, PAX2, TMEM100, CCL5, IL1B, AKT1, CCL2, EPHA2]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, PTGS2, THBS1, HMOX1, LYN, HSPA6, MYOF, EIF2S1, CXCL10, IL1A, TFEC]
GO:0045672;positive regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;6.599019797332524;0.0281402778535103;0.7337148045016781;[CCR1, TMEM64, FOS, TNF, POU4F1, IFNG, IL23A, CA2, TNFSF11, IL17A]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CPNE8, NLGN1, CAMK2D, CPNE5, SERPINE1, PHB2, ECT2, JUNB, KCNH1, MEF2A, MEF2C, JUN, EDN1, FOS, TUBG1, FOSB]
GO:0051781;positive regulation of cell division;5.0;0.6763753087927167;0.6284286662572787;8.438940185618286;42.28939918509474;5.358233019883872;0.0014153881327367882;0.5642612976810992;[CXCR5, TGFA, PDGFA, AURKB, FGF5, LBH, RACGAP1, PDGFD, NUP62, PDGFC, ECT2, SVIL, TGFB2, TGFB1, PRKCE, TAS2R13, OSM, CDC6, PPBP, CIT, EREG, BTC, IL1A, IL1B]
GO:0071398;cellular response to fatty acid;6.0;0.7369933605727446;0.6916169928765168;9.004369943419128;203.00017448222317;5.8067817141283475;0.006794233151624104;0.6200793994936333;[PID1, PTGER2, PTAFR, TNC, P2RY6, CCNB1, E2F1, AKT1, FFAR2, PTGDR, EDN1, DGAT2, PRKCE, NR1H4, NME1, IL1B]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3, CSF3R, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RB, PTPN6, IL1RN, IFI30, IFIT1, IFIT3, IFIT2, TNFSF11, TRIM25, RSAD2, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, EREG, IFI27, IL23A, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, IL10, SYK, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, LTB, CAMK2D, SAMHD1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0071276;cellular response to cadmium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.139487467954083;0.0026274528238337297;0.6370939872166814;[JUN, GSN, CHUK, NCF1, CYBB, FOS, MMP9, AKT1, HMOX1]
GO:0050691;regulation of defense response to virus by host;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;72.38922322033065;6.166155715036245;0.0024228021551132095;0.6662568552797195;[TNFAIP3, IFIT1, IL12RB1, DDX58, LILRB1, PARP9, MMP12, IL23A, IL1B]
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;570.2036429558796;6.221725566191056;0.019084202779771145;0.7334203466557586;[CX3CR1, STRADB, IFI6, TNF, GATA1, IL1A, IL1B, CTNNA1, BCL2, AKT1, SNAI2, FYN, PF4, BCL2L1]
GO:0090201;negative regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.8116675549172;6.943860283624253;0.015824581010188264;0.7513499630073597;[AKT1, ARRB2, CLU, BCL2L1]
GO:0033198;response to ATP;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;115.93137747960115;6.375876246018314;0.0038801188727762915;0.6491829203200885;[TRPC3, PTGS2, SLC8A1, P2RX5, SELL, P2RX1, IL1B]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[TNF, AKT1, CHUK, BTK, TLR8, TLR7, TLR4, CARD11, BIRC3, LY96, NLRC3, CD14, CARD9, NFKB1, NFKB2, NFKBIA, BCL3]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[PID1, ADARB1, PPP2R1A, AKT1, EPHB2, PAQR3, PRKCD, SFRP2, PRKAR1B, TRIB1, ATF3, TWIST1, THY1, PRKCZ, FLRT2, PRKAR2B, SFN, LYN, JUN, PLK1, LIF, NR2F2, CALM3, PKIG, CDKN1A, PTPRR, LRRC4, TIMP3, DUSP2, DUSP3, DUSP1, BGN, GP1BA, SIRT1, DUSP6, CEACAM1, IL1B, TLR4, ENG, LRRC19, FAM129A, NTF3, DMD, CDKN2C, PODN, NLRP12, PKN1, PYCARD, MEN1, CISH, IGFBP3, TSC2, FBLN1, FOXO1, SOCS2, CCNB1, TGFB1, CAV1, PTPRC, GNAQ, LRRK2, TNFAIP3, PTPN22, ARRB1, ARRB2, HHEX, DUSP10, LRRTM4, NUP62, EMILIN1, MYOCD, IRAK3, DCN, GREM1, ZMYND11, CEBPA, CSK, SNCA, KLF4, PTPN6]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, IL1RN, CSF3R, C5AR1, ITGB2, PIK3CD, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL2, XCL1, S100A9, S100A8, PF4]
GO:0040036;regulation of fibroblast growth factor receptor signaling pathway;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;67.94038154209638;6.375876246018314;0.002273903427840277;0.6491829203200885;[GATA3, SULF1, THBS1, RUNX2, DUSP6, SULF2, FAM20C]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[ITGB5, PTPRK, ARRB2, F11R, CDH5, FOS, SIRT1, TGFBR3, ADAM9, PRKCZ, JUN, TGFB2, TGFB1, USP9Y, PTK2, PML, COL3A1, COL1A2, ID1, ZYX]
GO:0045840;positive regulation of mitotic nuclear division;8.0;0.7140352122741334;0.7320176061370667;9.138976027173417;276.06341799230654;5.75172193694532;0.009239594159256459;0.6691433273378073;[CDCA5, TGFA, PHB2, NUP62, SH2B1, PDGFRB, RANBP2, RANBP1, EDN1, TGFB1, EGF, UBE2C, EREG, BTC, IL1A, IL1B, CD28]
GO:0042699;follicle-stimulating hormone signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;62.84085921303097;8.16763571524637;0.002103227004758593;0.7408135829017477;[LHCGR, ARRB1, ARRB2]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[F11R, TIAM2, DEPDC1B, RIN2, LLGL2, EPHA2, THY1, RACGAP1, NCKAP1L, A2M, JUN, EZH2, ARHGAP9, DENND1B, NRP1, CD40, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, DEPDC1, PLCB1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, DLC1, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP19, ARHGAP15, RASGRP1, ADAP2, ECT2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, GNAQ, ARHGAP11A, DOCK4, LRRK2, ARRB1, TAGAP, ARHGEF12, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL2, XCL1, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, ADAM8, S100A9, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, DOCK4, ITGB2, HMGB2, PIK3CD, CXCL1, ARRB2, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR2, IL10, ANXA1, FCER1G, SYK, RHOG, GAB1, VAV1, IL1B, KIT, XCL2, XCL1, HBEGF, CX3CR1, CCL13, LEF1, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0002711;positive regulation of T cell mediated immunity;8.0;0.7436939687323844;0.7468469843661922;9.271849308553389;266.2800456662771;5.9928839937622085;0.008912153491967712;0.6814763661386056;[CD1E, GATA3, CD1D, CD1C, CD1B, PRKCZ, CD1A, HSPD1, NLRP3, IL12RB1, FZD5, RSAD2, IL18, IL6, IL23A, IL1B, XCL1]
GO:0051044;positive regulation of membrane protein ectodomain proteolysis;9.0;1.0;0.896240625180289;9.628524252492122;964.0127980139503;7.069023426578259;0.03226464079433516;0.757750811958709;[IFNG, IL1B, ADAM9, ADAM8, TNFRSF1B, TNF]
GO:0071333;cellular response to glucose stimulus;8.0;1.0;0.875;9.628524252492122;272.3004295980195;5.69953618377475;0.009113650324169357;0.6664745454937787;[LGALS1, SOX4, MEN1, PAX2, NME1, LIN28A, IL1B, NOX4]
GO:0031398;positive regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;528.4459358446122;5.113634533568402;0.01768660990225356;0.6767525197159333;[LRRK2, PTPN22, ARRB1, BRCA1, ARRB2, BMI1, CDC20, SKP2, BIRC3, ADRB2, NOD2, FANCI, NDFIP2, WFS1, UBE2C, CAV1, PLK1]
GO:0050999;regulation of nitric-oxide synthase activity;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;24.724602712185703;6.039404009397101;8.275102020790521E-4;0.6319757144917204;[CNR1, AKT1, GCH1, CAV1, DNM2, FCER2, IL1B]
GO:0033574;response to testosterone;5.0;0.9326813400603323;0.7565816818910864;9.533214072687796;91.03892825708995;6.063501560976162;0.003046990999048697;0.6003287636709002;[THBS1, PLN, SPP1, EDN1, DUSP1, CAD, NME1, NASP]
GO:0031397;negative regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;529.4632463014641;5.572381008289503;0.01772065836772442;0.7002128357670632;[TNFAIP3, ARRB1, ARRB2, AKT1, FBXO5, SOX4, PRKCE, FYN, CAV1, ISG15, MAD2L1]
GO:0050995;negative regulation of lipid catabolic process;7.0;0.7671156992804218;0.7344772148974115;9.0689084645567;114.83297947662612;6.686031174322154;0.003843356480110741;0.692843310444282;[CNR1, IL1B, AKT1, TNF]
GO:2000279;negative regulation of DNA biosynthetic process;8.0;0.7980440201809971;0.7740220100904985;9.434368238051164;829.3243434921358;6.166155715036245;0.02775673943322936;0.6903374900225189;[DUSP1, DACH1, MEN1]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[TGFB1, C5AR1, RORA, BRCA1, PTGS2, SULF1, SULF2, C3, IL1A, IL1B, C3AR1, CYP1B1, HPSE, NOX1]
GO:0050996;positive regulation of lipid catabolic process;7.0;0.7248374789738407;0.7133381047441208;8.85533436425864;114.22740612088849;6.641579411751319;0.0038230884848748396;0.6905700452391912;[FABP1, IL1B, PRKCE, PRKCD, TWIST1]
GO:0046827;positive regulation of protein export from nucleus;9.0;0.811012628672052;0.801746939516315;9.431813958246067;516.7269860224134;6.7325511899570465;0.017294387198074676;0.740543606130341;[IL1B, SFN, CAMK1]
GO:2000173;negative regulation of branching morphogenesis of a nerve;7.0;1.0;0.8509193652572005;9.628524252492122;148.90868040495974;9.777073627680469;0.0049838395240422466;0.8509193652572005;[IL1B]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[HMGB2, PTPN22, IFIH1, DHX58, CHUK, SYK, DDX58, MMP12, IRF7, TLR8, TLR7, TLR4, TLR2, HSPD1, CD14, NFKB1, NFKB2, MYD88]
GO:0060559;positive regulation of calcidiol 1-monooxygenase activity;10.0;1.0;0.9152410118609203;9.628524252492122;1344.9571378328073;8.67846133901236;0.04501450502042472;0.8590579283277371;[IFNG, IL1B, TNF]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0008277;regulation of G-protein coupled receptor protein signaling pathway;6.0;0.5383299095163034;0.5922852673482962;7.5335785242763205;41.8512380110395;4.8942717050940985;0.0014007232725606145;0.5734135951955668;[, LRRK2, GUCA1C, ARRB2, RGS1, STMN1, EDN1, ADCYAP1, ACPP, PLCB1, ADRB2, RASGRP4, GNAI2, C3, CCL5, SNCA, CAV2, RAMP1]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[CYFIP1, SPARC, CTGF, EDNRB, SESN3, AKT1, PRKACB, MEN1, GHSR, LHCGR, IGFBP5, PRKCD, CYBB, EREG, POR, ADCY9, RAB31, PRKAR1B, ABCB4, SLC30A10, FOXO1, PRKAR2B, CYC1, LYN, EGR1, EGR2, EIF2B3, TGFB1, CAV1, CDC6, NFKB1, NR4A2, COL1A1, NR4A1, CXCL12, NR4A3, FBN1, BTG2, ADM, HHEX, TIMP1, IL10, EDN1, ANXA1, ARG1, GLP2R, CAD, SIRT1, TGFBR3, CCNA2, CEACAM1, IL1B, TLR2, RETN, PTGS2, GNAI1, PAK1, PLN, FYN, CSK, SORT1, SORBS1, TSHR, TEK]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, SPARC, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, HSPG2, RAB31, CALCRL, CFI, FPR2, ADRB2, IGLV1-44, CD14, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, DAB2, IGKV3-20, LRP12, ACHE, ITGB2, ADM, ARRB1, ARRB2, ASGR1, ASGR2, STAB1, CD36, FCER1G, SYK, ITGA4, DNM2, CEACAM1, COLEC12, LRP1, CD5L, TMPRSS2, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1A, FCGR1B, SNCA, LILRB1, CD6, SNX17, CD5, NEDD4, CD9, FCGR2B, RAMP1]
GO:2000727;positive regulation of cardiac muscle cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.4949928598676;667.9527156383532;6.8867018697843045;0.02235577627399952;0.7484268790654467;[GREM1, MEF2C, MYOCD, EDN1, TGFB1, ARRB2]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, ETS1, CTGF, RUVBL2, CD38, PDGFRB, IL10, GHSR, POSTN, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, CST3, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0035505;positive regulation of myosin light chain kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1426.5997261217476;9.777073627680469;0.0477470089768964;0.9481203125901445;[IL1B]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, CSF3, NCF1, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, FAM3D, EPHB2, PHLDA2, MED1, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, IFNA10, CALCA, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, FBN1, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, SECTM1, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, TNFSF12-TNFSF13, IL10, EDN1, IL18, GREM1, IL1A, IFNG, IL1B, LTA, XCL2, XCL1, LTB, SHANK3, HBEGF, CCL13, NLGN1, GRN, CLEC12B, RETN, TYMP, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, SPP1, CCL2, CCL1, CCL19, CCL18, IL32, CMTM8, IL33, CCL23, CCL21, EGF, CCL20, OSM, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[SIRPG, TNF, SIRPB1, C2, PYCARD, C3, STAP1, CCL2, SIRPA, NCKAP1L, CD36, FCER1G, SLC11A1, AZU1, DNM2, IL1B, PTX3, FCGR2B]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[AKT1, MED1, CDCA3, BARD1, HACE1, PLK1, SIRT1, RNF130, RNF43, CISH, FBXW2, CUL5, SOCS2, MARCH3, MARCH1, BCL2, ARRB1, ARRB2, BIRC5, DTL, BIRC3, NLRC4, RNF24, CDC20, HERC5, TRIM25, SKP2, CDC34, NAIP, BRCA1, BMI1, RNF144B, PDZRN3, PCNA, NEDD4, KLHL14, DTX3, UBE2C, UBE2M, TNFAIP3, HIST1H2BK]
GO:0035066;positive regulation of histone acetylation;11.0;0.811012628672052;0.8379352666656883;9.498471124243924;1302.9179711131005;6.444869117505266;0.043607491943109866;0.7620198587159455;[TGFB1, LIF, ARRB1, GATA3, BRCA1, IL1B, RUVBL2]
GO:1904037;positive regulation of epithelial cell apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.148951172230236;105.42595785554589;6.375876246018314;0.0035285119322230004;0.701062607729944;[CD40, GSN, ITGA4, SORT1, FASLG, ARRB2, EIF2S1, THBS1, SFRP4, IL6, CD40LG, CCL2, PLCG1]
GO:1902895;positive regulation of pri-miRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1721.2385553242598;6.599019797332524;0.0576083054325737;0.7855944919115336;[JUN, TGFB2, BMP2, TGFB1, KLF5, SPI1, PRL, FOS]
GO:0045746;negative regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;188.1075192762445;6.193554689224359;0.006295789384399518;0.6676580400938822;[EGF, ARRB1, NFKBIA, BCL6]
GO:0070262;peptidyl-serine dephosphorylation;8.0;1.0;0.875;9.628524252492122;179.24922260518233;7.292166977892469;0.005999310166768488;0.747921758369865;[PPP2R1A, DUSP1, PPP1CA]
GO:0034765;regulation of ion transmembrane transport;6.0;0.45556283921517005;0.5509017321977295;6.676594601596523;33.03735142972539;3.697140432584879;0.0011057304206669666;0.512192246247148;[, KCNG2, FMR1, SLC8A1, AKT1, EPHB2, SCN1A, KCNH1, KCNH2, MEF2C, DAPK1, PRKCE, F2R, CACNA2D3, CYBB, ACTN4, ATP1B2, PDZK1, ATP1B1, GEM, KCNQ1, CFTR, KCNE3, KCNE4, HVCN1, TWIST1, ADRB2, THY1, CACNA1F, CORO1A, CD19, PLCG1, SCN3A, DRD4, LYN, TGFB1, CAV1, CXCL10, CXCL11, EHD3, FXYD2, FXYD6, CALM3, NOX1, KCNK5, CXCL9, CLIC3, CTSS, GRM5, JPH2, PDE4B, YWHAH, KCND2, GPR35, TRPC1, MMP9, DNM2, TMEM37, XCL1, SHANK3, NLGN1, CAMK2D, PTAFR, KCNA5, THBS1, PLN, FLNA, DMD, FYN, SNCA, SLC31A2, KCNJ15, KCNJ16, TSPAN13, NEDD4, FKBP1B, GOPC, PTPN6, F2RL3]
GO:2000178;negative regulation of neural precursor cell proliferation;6.0;0.7980440201809971;0.722142322680643;9.117698628726131;64.43316573945785;6.781341354126479;0.002156520071215264;0.6699184248047958;[BTG2, TGFB1, SPINT1, IL1B, CTNNA1, SPINT2]
GO:0071236;cellular response to antibiotic;4.0;0.6369964171292115;0.5684982085646058;7.703233390639544;41.40086873190647;5.085725745451326;0.0013856498180940687;0.5100842511328143;[SPI1, TNFAIP3, ETS1, AQP1, IL18RAP, MYB, CYP1B1, MEF2C, ANXA1, ARG1, PRKCE, PRKCD, CYBB, SIRT1, PAX2, IL1B, CFTR, PCNA, ABCB4, GNAI1, FOXO1, CST3, CCL7, PDGFD, ECT2, EGR1, KLF4, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0032226;positive regulation of synaptic transmission, dopaminergic;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;135.83014596643335;7.8311634786251565;0.004546112746301595;0.7754860644832351;[ARRB2, DRD4]
GO:0035176;social behavior;3.0;1.0;0.6981203125901445;9.628524252492122;22.58175877758554;5.8067817141283475;7.557911440223213E-4;0.49507939949363344;[NLGN4Y, NRXN3, AVPR1A, IL1B, DNAJC9, SHANK3, DRD4]
GO:0035970;peptidyl-threonine dephosphorylation;8.0;1.0;0.875;9.628524252492122;179.24922260518233;7.004484905440688;0.005999310166768488;0.7332096838060964;[DUSP1, PPP1CA, DUSP10]
GO:0051085;chaperone cofactor-dependent protein refolding;5.0;1.0;0.7902410118609202;9.628524252492122;21.14140270213274;6.409777797693995;7.075837224132252E-4;0.618037346520142;[CD74, HSPA6, HSPE1]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB2, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, SH2D2A, TXK, TGFA, PDGFA, SLC30A10, PRKCZ, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PILRA, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, GAB2, VAV1, HCK, KIT, PLCB1, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF1, SULF2, NCF1, NCF2, NCF4, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, MATK, TSC2, CYBB, PDGFRL, DOK2, COL4A2, CD8B, KIF16B, COL4A1, CD8A, BLK, CSF1R, CUL5, RASGRP4, FOXO1, SOCS2, STAP1, TGFB1, CAV2, CRIM1, BMX, VIL1, GH1, NR4A3, FES, CSPG4, ITGB3, GHR, BLNK, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, CD4, CD7, TEK]
GO:0002031;G-protein coupled receptor internalization;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;66.79409571189065;7.379178354882098;0.0022355382726935618;0.7523715242355574;[ADM, ARRB1, ARRB2, DNM2]
GO:0002032;desensitization of G-protein coupled receptor protein signaling pathway by arrestin;9.0;1.0;0.896240625180289;9.628524252492122;416.97188309209935;9.083926447120524;0.013955673676761097;0.8607930461318132;[ADRB2, ARRB2]
GO:0007602;phototransduction;6.0;0.811012628672052;0.7286266269261705;9.34084218004034;75.43405895496794;6.039404009397101;0.0025247100669772656;0.6319757144917204;[TRPC3, GNAQ, ARRB1]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[ITGAM, CTSZ, ITGB2, FASLG, CLU, MYB, FOS, KMO, CDC34, IL1B, TLR6, TLR4, TP53BP2, FYN, SNCA, EGR1, JUN, TGFB2, EIF2S1, FCGR2B, UBE2M]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD86, IL1A, CD4, CD80, IL1B, CD28, PRKCQ, CD3E, CARD11]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CSF3, CD80, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, RARA, ADAM9, TLR4, CX3CR1, CD274, CEBPB, CEBPE, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, NR1H4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:2000866;positive regulation of estradiol secretion;9.0;1.0;0.896240625180289;9.628524252492122;439.69537685412286;8.67846133901236;0.014716208563159352;0.8400575416471059;[IL1B, SPP1]
GO:0071223;cellular response to lipoteichoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;155.87545856417063;7.474488534686424;0.005217011319337755;0.7053660038532718;[CCL20, TREM2, CD36, CD14, MAPK14, TLR2]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[PTPRR, FBLN1, ARRB1, DUSP10, TIMP3, CSK, EMILIN1, EPHB2, LYN, DUSP3, DUSP1, LIF, KLF4, DUSP6, NLRP12, TLR4, ATF3]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, RNASE6, RNASE3, MIF, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, IGKC, CARD9, NR1H4, KIR3DL1, LGR4, C1QC, FCN1, NCF1, NCF2, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PDGFD, PDGFC, SLAMF1, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, ARRB1, ARRB2, CCR7, CD36, HAVCR2, IL1B, KIT, XCL2, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0070498;interleukin-1-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.845247994956144;0.00101047745553359;0.6498456195510879;[IL1RN, NOD2, EGR1, CHUK, IL1R1, IL1R2, IRAK3, NFKB1, NFKBIA, IL1A, IL1B, PLCB1, MYD88]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[IL10, LILRB1, IRAK3, ARRB2, THBS1, NFKB1, TLR8, TIGIT, JAK3, SLAMF1]
GO:0045080;positive regulation of chemokine biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.597752593825367;840.1940438043877;7.697632086000634;0.02812053852058526;0.7686572628545723;[EGR1, IL1B, HMOX1, AZU1, TNF]
GO:0043507;positive regulation of JUN kinase activity;13.0;0.8653626801206646;0.8952363048279688;9.582714716460828;4931.413721535565;5.459585514144159;0.16504997927558432;0.7417584218576596;[IL1RN, TNF, TNFSF11, MAP4K1, EDN1, SYK, MDFIC, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, FZD5, FZD8, CD40LG, PKN1]
GO:0045807;positive regulation of endocytosis;7.0;0.6873818243518346;0.6946102774331178;8.89763674394933;124.48668476360231;4.886724499458715;0.0041664573082951335;0.6008266834154484;[LRRK2, FMR1, SIRPG, SERPINE1, ARRB1, ARRB2, TNF, CLU, SIRPB1, PYCARD, SIRPA, CD36, FCER1G, SYK, SLC11A1, ACTN4, DNM2, GREM1, SFRP4, IL1B, NLGN1, CD151, LRP1, DLL1, C2, RAB21, C3, NTF3, STAP1, CCL2, NCKAP1L, CCL19, CD14, SNCA, CCL21, EGF, AZU1, SELE, TF, DAB2, PTX3, FCGR2B]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[, NUP107, TFRC, AKT1, WLS, GATA3, LYN, ABCA1, COL1A1, MMP12, CENPF, SNX17, GOPC, NCF1, CSE1L, AP2M1, ADCYAP1, ACAP1, SLC27A2, LIN7A, EVI5, ARRB1, ARRB2, TNFSF13B, ITGB6, ARL4C, LCP2, LRP1, LRP2, GOLPH3L, HNF1B, ACTN4, MSR1, EGR2, POLA2, TF, CD24, CD3G, AKAP12, CCR7, CD36, SYK, NAPA, HSD17B4, STX11, CD74, NEDD4, FKBP1B, RAMP1, SCARB2, CARD11, ECT2, NUP155, NASP, NUP62, YWHAH, NUP133, TBC1D9, CHI3L1, NUP54, MX2, NUP35, RAN, PHB2, HOMER3, CUBN, NUP85, S100A12, NUP88, EHD3, DENND1B, ANXA1, CCL19, NR1H4, TNF, CLU, LAMP2, TAP1, RAB32, RAB31, CALCRL, SLC15A3, DAB2, BCL6, BCL3, CCDC22, NLGN1, UNC93B1, NLRC4, NOD2, RAB21, PML, VPS41, IL1RN, IFIT1, ARFIP1, STXBP2, AHCTF1, TRAM2, XPO1, TMED6, STRADB, ZDHHC17, RAB33B, TLR6, TLR4, TLR2, RANBP2, RANBP1, LILRB1, RANBP6, CD40LG, NUPL2, STEAP3, GOLT1B, TSC2, ATP1B1, HGS, COPB2, SUCNR1, NLRP3, TGFB1, LRP1B, NFKBIA, TBCK, KIF18A, DNM2, IFNG, EHHADH, HSPD1]
GO:0051928;positive regulation of calcium ion transport;8.0;0.7043150770688792;0.7271575385344395;8.848365694942547;69.31158403183679;5.085725745451326;0.002319796341169766;0.6350842511328143;[CXCL9, ARRB2, MYLK, LGALS3, JPH2, PDGFRB, TRPC3, TRPC1, F2R, ATP1B1, XCL1, KCNE3, THY1, CD19, CCL5, CCL4, CCL2, PLCG1, SNCA, CCR1, WFS1, CAV1, CXCL10, P2RX5, CD4, CXCL11, EHD3, CXCL12, CALM3, F2RL3]
GO:0046579;positive regulation of Ras protein signal transduction;9.0;0.8259837884571596;0.8092325194088689;9.394909401310617;287.86983276338884;5.905872616772578;0.009634744236561129;0.6982672254532021;[PDGFRB, GPR35, F2R, ARRB1, RASGRP1, RASGRP4, COL3A1, GPR18, F2RL3]
GO:0060765;regulation of androgen receptor signaling pathway;7.0;0.8436909121759173;0.7727648213451592;9.427853557029971;43.64299748026755;6.518977089658987;0.0014606918495168463;0.6843001567857983;[KDM5D, ARRB2, SIRT1, DAB2]
GO:0032967;positive regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;105.22247330055487;6.558197802812269;0.003521701487291661;0.6585068532133508;[PDGFRB, TGFB1, MYB, F2R, IHH, ARRB2, ENG, CTGF]
GO:0032725;positive regulation of granulocyte macrophage colony-stimulating factor production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;7.212124270218933;0.0021737836760178982;0.6919486831672181;[SYK, IL23A, DDX58, CD80, IL1B, IL18, RASGRP1]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, RORA, PHB2, ETS1, SLC8A1, LOXL2, AQP1, EDNRA, PLAU, MYB, AKT1, POSTN, PRKCE, ACTN4, ATP1B1, CLDN3, ADAM8, ABCB4, PSEN2, TWIST1, DPP4, CCNB1, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, BCL2, NOX4, CD24, ALAS2, SUV39H1, ADM, ALAD, CD38, MYOCD, ADSL, EDN1, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, TLR2, CXCR4, KCNA5, PTGS2, THBS1, ASCL2, CST3, PAK1, E2F1, PML, FABP1, TEK]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[LY96, HSPD1, CD36, CD14, IRAK3, TLR1, BTK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, MYD88, TLR2]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, SLC11A1, IL18, IL23A, IL1B, LTA, TLR8, TLR7, TLR4, TXK, RASGRP1, HSPD1, KLRK1, CD14, IL12RB1, IL12RB2, FZD5, CD2, BCL3, HLA-DPB1, IL18R1, CD244]
GO:0050712;negative regulation of interleukin-1 alpha secretion;11.0;1.0;0.9324289523296623;9.628524252492122;999.3037873052855;9.777073627680469;0.033445798446087804;0.9324289523296623;[IL1R2]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, JAK3, DUSP1, GMIP, SIRT1, DUSP6, PTAFR, STAT4, DMD, PKN1, LGR4, CTGF, SESN3, KCNH1, KCNH2, CISH, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, TNFRSF10B, BMX, CORO2A, NFKB1, NFKB2, LRRK2, PIK3CD, TNFRSF1B, LCP2, LCP1, DTL, BIRC3, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, TRIB1, RIN2, EPHA2, RACGAP1, CD14, PAG1, CCR1, PTK2, CALM3, RGL4, CD24, RGL1, CD40, CETN3, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR2, IL18, GAB2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK2, DOK3, TYROBP, CARD11, CALCA, PSEN2, RASGRP1, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, GNAQ, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, EPS8L1, EPS8L3, EGF, MAPK14, MAPK13, TEK, CYFIP1, EPS8, STMN1, CYP1B1, MED1, PRKCH, DAPK1, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, PRKCZ, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, BTG2, ADM, IFIH1, NFAM1, PAX2, CIT, PLCB1, HBEGF, GSN, CCL20, CARD9, POU4F1, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, RAB31, CSF1R, CALCRL, CUL5, ITPR3, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK1, BCL2, CSPG4, LAT, BCL2L1, TREM1, CHUK, TFDP1, IL3RA, CX3CR1, CEBPB, NLRC3, NOD2, RAB21, PLN, PML, DNAJA3, CALML4, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, STRADB, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, GUCY2C, SP100, PTGER2, CXCR5, CXCR4, CXCR6, AIF1, CXCR1, CXCR3, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, CSF2RA, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, ZAP70, CAMK2D, NCAM1, TSHR]
GO:0032720;negative regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;5.926926025970411;0.002875903446815721;0.6540226378555745;[ORM1, TNFAIP3, TWIST1, PTPN22, NLRC3, ARRB2, GPNMB, CD34, HAVCR2, SLAMF1, IL10, GHSR, NR1H4, LILRB1, IRAK3, BCL3, RARA, BPI, TLR4, GPR18]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, CSF3, IFNA2, ARRB1, ARRB2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, MIF, SFRP2, IFNG, IFNA10, PTGS2, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, OSM, IL6, BCL2, CAMK1]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[GREM1, SFRP4, SYK, EGF, FMR1, NTF3, ARRB1, ARRB2, SELE]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, ETS1, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, PCNA, KCNA5, FOXO1, CST3, PDGFD, HMOX1, ECT2, JUN, KLF4, MAPK13, COL1A1, FABP1, IL6, NR4A3, FKBP1B, CDK1, BCL2, SDC1, EZH2]
GO:0042663;regulation of endodermal cell fate specification;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;108.59969873383258;8.390779266560578;0.0036347341832379046;0.8041048419030481;[HNF1B, DUSP6]
GO:0045931;positive regulation of mitotic cell cycle;6.0;0.6073376606709605;0.6267891429256247;8.04155919591008;60.92102604112766;4.779861353916354;0.0020389719162326697;0.5675626445157116;[BRCA2, PHB2, NUP62, PDGFRB, EDN1, ANXA1, DUSP3, CDC25A, EREG, BTC, IL1A, RAD51C, IL1B, PLCB1, DTL, SMARCD3, CDCA5, TGFA, KCNA5, AIF1, CCNB1, SH2B1, RANBP2, RANBP1, TGFB1, EGF, UBE2C, CDC6, MEIS2, NDC80, CD28, CDK1, MAD2L1]
GO:0032715;negative regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.96654663153603;6.166155715036245;0.002174371849661483;0.6384578026126634;[ORM1, TNFAIP3, PTPN22, NLRC3, ARRB1, ARRB2, TNF, INPP5D, NCKAP1L, CSK, HAVCR2, SLAMF1, IL10, GHSR, NR1H4, IRAK3, NLRP12, BANK1, BPI, TLR4]
GO:0010829;negative regulation of glucose transmembrane transport;7.0;0.8933024483968273;0.7975705894556142;9.533214072687796;65.66986041637082;6.832634648514029;0.002197911129098591;0.7003406189322132;[PID1, IL1B, TNF]
GO:0032717;negative regulation of interleukin-8 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.943860283624253;0.002184000309729388;0.6782296504172152;[IL10, ANXA1, PTPN22, ARRB1, KLF4, BCL3, BPI, TLR6, ELANE]
GO:0030099;myeloid cell differentiation;4.0;0.6913464685778243;0.5956732342889122;8.146919711567906;21.066225782797595;4.720827822332161;7.050676185779127E-4;0.49142335437501145;[CSF3, SPI1, TFRC, IKZF1, TNF, CLEC5A, TNFSF11, JUNB, MED1, MEF2C, ACTN1, OSCAR, TYROBP, PRTN3, HOXB7, TRIM10, EPHA2, CSF1R, TNFRSF11A, GATA3, GATA1, RASGRP4, NKX2-3, LYN, JUN, TGFB1, NBEAL2, INHBA, ALAS2, PIK3CD, TREM2, HHEX, CCR7, JAK3, FCER1G, GAB2, MMP9, SIRT1, CBFA2T3, TGFBR3, KIT, CEBPA, CEBPE, LEF1, AHSP, CCL19, MAPK14, PML, KLF1, CAMK4, ACIN1, PTPN6, LTBR]
GO:0031622;positive regulation of fever generation;9.0;0.8436909121759173;0.8180860812682478;9.454170865347344;276.00155245721845;7.8311634786251565;0.009237523575472428;0.7967266896635242;[CNR1, IL1B, TNFSF11, TNFRSF11A, PTGS2, TNF]
GO:0050965;detection of temperature stimulus involved in sensory perception of pain;6.0;1.0;0.8231203125901445;9.628524252492122;60.1825293085583;7.069023426578259;0.002014255095197483;0.6846304993685643;[CALCA, CXCL12, ARRB2, EPHB1]
GO:0033129;positive regulation of histone phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1473.5624568792941;7.697632086000634;0.04931880931163779;0.8088982747154926;[CCNB1, IL1B, FMR1]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[IL1RN, AQP9, IFIT1, AQP1, LGALS1, AKT1, CYP1B1, MED1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, BRCA1, IFIH1, IL10, EDN1, ANXA1, ARG1, IL18, IL1B, PTAFR, PTGS2, AIF1, GNAI1, CTNNA1, SPP1, P2RY13, POU4F1, TNC, RORA, TNF, SLC8A1, CDH1, RUVBL2, IGFBP5, ADCYAP1, BLM, FECH, FOXO1, CCNB1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, BMP2, KIF18A, NR4A3, ALPL, SLC26A3, LRRK2, PDE4B, DDX58, DNM2, CCNA2, COLEC12, CEBPA, CEBPB, NOD2, P2RY6, CCL5, CCL2, SNCA, KLF4, RAD51, KLF5]
GO:0035666;TRIF-dependent toll-like receptor signaling pathway;13.0;0.9326813400603323;0.9288956347978027;9.592156608321247;413.3481394832653;6.599019797332524;0.013834390239330937;0.8000291440890255;[CHUK, LY96, IRF7, TLR6, CD14, TLR4]
GO:0060420;regulation of heart growth;6.0;0.7586651285174919;0.7024528768488905;9.260799472366804;65.94608890727007;5.75172193694532;0.0022071562480994867;0.6172636399279519;[MEF2C, EDN1, MAPK14, DUSP6, TGFBR3, PAK1, MEIS1, CCNB1, BASP1, CDK1]
GO:1903140;regulation of establishment of endothelial barrier;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;90.35426377509846;7.292166977892469;0.003024075894994471;0.747921758369865;[CDH5, IL1B, S1PR3, TNF]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[PTPN22, DUSP10, PPP2R1A, NUP62, DUSP2, DUSP3, DUSP1, PAQR3, PRKCD, IRAK3, DUSP6, SFRP2, IL1B, LYN, CAV1, PTPN6]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPARC, LST1, SPINT2, ADARB1, PHB2, IFIT3, CYP1B1, EPHB1, SOX7, SOX4, MED1, MEF2C, EREG, SFRP4, SFRP2, SPINT1, BTK, TRIB1, GATA3, GATA1, INPP5D, HMOX1, SFN, S100A11, LYN, JUN, BCL11B, FZD5, LIF, EIF2AK2, CDC6, NR2F2, NOX4, SNAI2, CDKN1A, BTG2, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, HNF4A, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, NME1, IL1A, CEACAM1, IL1B, RARA, TLR2, PTGS2, ASCL2, AIF1, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, OSM, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CD86, CD80, SIRPG, IHH, TNF, ETS1, CDH5, DACH1, MEN1, IGFBP5, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, MAD1L1, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, BCL6, OGN, BCL2, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, KLF13, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPA, CEBPB, NLRC3, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, SOD2, PML, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, PRKCH, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PDGFA, IQGAP3, GATA1, PRKCZ, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, JUN, FN1, CDC6, NOX1, CDKN1A, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, FCRL3, SIRT1, F3, PAX2, MMP12, RARA, HBEGF, PTAFR, KCNA5, PTGS2, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, LRG1, HLA-DPB1, CSF3, CHRM1, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, PPP1R16B, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, BCL6, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, ARRB1, CYR61, TNFSF13B, LBH, ITGA4, XCL1, BIRC5, CX3CR1, SMARCD3, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, PTPN6, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, FLT3LG, MIF, RUNX2, EREG, BTC, SFRP2, IL23A, TGFA, TWIST1, CD1D, PKHD1, SLAMF1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR2, IL10, EDN1, SYK, RHOG, IL18, PDCD1LG2, AVPR1A, GAB2, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, AIF1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, OSM, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, ETS1, IL6R, PDGFRB, GHSR, PDGFRA, MATK, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, LEF1, DLL1, THBS1, HLX, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, TEK]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, GATA3, GATA1, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, RARA, ENG, NR1I2, EPCAM, STAT4, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, CEBPD, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RXRA, IL33, CDX1, OSM, LILRB1, GRHL2, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[CTSZ, FASLG, MYB, JUN, TGFB2, CDC34, IL1B, UBE2M]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, BTG2, ARRB1, ARRB2, CHL1, MEF2C, F2R, MSH2, ADAM8, NAIP, CEBPB, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, SOD2, POU4F1, NR4A2, NR4A3, BCL2, BCL2L1]
GO:0007628;adult walking behavior;4.0;1.0;0.75;9.628524252492122;34.938319875750295;6.518977089658987;0.0011693541237948906;0.5833807915285978;[ABHD12, ARRB2, SCN1A]
GO:2000778;positive regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.0674169630446;6.599019797332524;0.02068616022119099;0.7527151911823093;[DDX58, F2R, TWIST1, PYCARD, IFIH1, IL1B, TLR8, IL17A]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, AIF1, FOXO1, IGFBP7, TGFB1, IL6, BCL2, ALPL, SDC1, FOSB]
GO:0070588;calcium ion transmembrane transport;9.0;0.7140352122741334;0.7532582313173557;9.078477915572849;116.6808485568922;4.562137870071484;0.003905202995253044;0.629548568016852;[DENND5B, ATP2A3, FASLG, PHB2, SLC8A1, JPH2, CCR7, CCR5, TRPC7, TRPC3, TRPC1, PRKCE, F2R, CACNA2D3, TMEM37, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, CUL5, ITPR3, ATP2C2, CACNA1F, CCL19, CCL21, PTPRC, FKBP1B]
GO:0035774;positive regulation of insulin secretion involved in cellular response to glucose stimulus;11.0;1.0;0.9324289523296623;9.628524252492122;1297.4197001833559;6.375876246018314;0.043423469763213894;0.7584915600596062;[NR1H4, ARRB1, TMEM27, CFTR]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CSF3, NCF1, CD80, ITGB3, IFNA2, TREM2, ARRB2, CD3E, GHR, GRM5, CD36, IL6R, SYK, IL18, MIF, PARP9, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HBEGF, CSF1R, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, CD74, TGFB1, ACE, EGF, LIF, OSM, GH1, CD4, IL6, CSPG4, CD24]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[CDC20, RUVBL1, PSMD3, SKP2, CDC25A, CFTR, PSMD14, ADRB2, GATA3, NLRP3, BARD1, NFKBIA, COPS5, CDK1, TNFAIP3, BRCA1, ARRB2, IFIH1, DDX58, ACTL6A, PSMA5, CCNA2, PSMA6, PSMA3, PSMA4, PSMA2, BIRC3, FAM105A, USP1, IL33, USP9Y, PSMC6, PSMC2, EIF3F]
GO:0033591;response to L-ascorbic acid;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;69.44758579076571;7.9853141584524145;0.0023243481976474804;0.7592887026755414;[SPARC, IL1B]
GO:0038124;toll-like receptor TLR6:TLR2 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.390779266560578;0.013811191226989502;0.8772251544931927;[CD36, TLR6, CD14, TLR2]
GO:0038123;toll-like receptor TLR1:TLR2 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.67846133901236;0.013811191226989502;0.8919372290569614;[TLR1, CD14, TLR2]
GO:0014050;negative regulation of glutamate secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;415.4544886335298;7.8311634786251565;0.013904887849799128;0.7967266896635242;[IL1RN, IL1B]
GO:0001660;fever generation;7.0;1.0;0.8509193652572005;9.628524252492122;35.726156595412796;8.16763571524637;0.0011957223097949796;0.7686126355688037;[IL1A, IL1RN, IL1B]
GO:0001661;conditioned taste aversion;8.0;1.0;0.875;9.628524252492122;32.407272069964435;8.16763571524637;0.001084642231530376;0.7926932703116032;[FOS]
GO:0045953;negative regulation of natural killer cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.526741558182179;431.6560499367194;7.379178354882098;0.014447139526158352;0.7736121494158466;[CEACAM1, CLEC12B, LILRB1, SERPINB9, ARRB2, HAVCR2]
GO:0050860;negative regulation of T cell receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;309.61561130321576;6.8867018697843045;0.010362555874359037;0.7271862538851576;[LGALS3, CEACAM1, DUSP3, PVRIG, PAWR, PTPN22, PTPN6, UBASH3A, THY1]
GO:0006306;DNA methylation;9.0;0.7436939687323844;0.7680876095464813;9.253830803050711;389.4685312710283;5.948432231191374;0.01303516124271949;0.7004437261138039;[EHMT2, FOS, EZH2]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, CSF3, SPARC, CD80, SERPINE1, CXCL13, MPO, LOXL1, PYCARD, EDNRB, JUNB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, TRIB1, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, NFKB2, SELP, CXCL10, CXCL11, IL6, ALPL, CD27, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, ADM, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, RARA, TLR4, CX3CR1, CEBPB, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, NR1H4, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:0050868;negative regulation of T cell activation;8.0;0.6393367784920305;0.6946683892460153;8.866384200445225;233.2008977034727;5.132682728539097;0.007805024178953029;0.6374856334316459;[CD86, CD80, IFNA2, IHH, PTPN22, LRRC32, LGALS3, CTLA4, JAK3, HAVCR2, IL10, LAG3, ANXA1, DUSP3, ARG1, PAWR, PDCD1LG2, CEACAM1, XCL1, PDE5A, MAD1L1, CD274, CEBPB, GPNMB, HLX, TBX21, TIGIT, PAG1, CD74, TGFB1, LILRB1, LILRB2, BCL6, PTPN6, FCGR2B]
GO:2000660;negative regulation of interleukin-1-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;306.2706419112467;8.16763571524637;0.010250602759086841;0.7926932703116032;[IL6, IL1RN, IL1R2]
GO:0071548;response to dexamethasone;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;124.89021324540595;6.015873511986907;0.004179963043429046;0.6826520511697386;[PCNA, FECH, ABCB4, PTAFR, FOXO1, AQP1, GHSR, EDN1, TGFB1, ARG1, IL1B]
GO:0034393;positive regulation of smooth muscle cell apoptotic process;9.0;0.9326813400603323;0.8625812952104552;9.56398573135455;127.00837127343294;7.212124270218933;0.004250855886408647;0.7650689957573628;[IFNG, ARRB1, SOD2]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[NRP1, CSF3, PLXND1, LRRK2, ARRB1, MEN1, MEF2C, MMP9, LRP1, EPB41L5, CTHRC1, PLK2, CAV1, BMP2, RAN]
GO:0034392;negative regulation of smooth muscle cell apoptotic process;9.0;0.9326813400603323;0.8625812952104552;9.56398573135455;127.11293359827955;7.9853141584524145;0.004254355493321279;0.8046099625986299;[EDN1, ARRB2]
GO:0007212;dopamine receptor signaling pathway;6.0;0.8653626801206646;0.7558016526504768;9.271849308553389;26.976932752798508;6.166155715036245;9.028936615729279E-4;0.6384578026126634;[GNA15, GNAQ, FLNA, ARRB2, DRD4]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, JUNB, HOXA5, SOX4, MEF2A, MED1, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, TXK, GATA3, GATA1, NHLH2, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, PLSCR1, TFEC, SATB2, FLNA, CDX2, CDX1, GTF2H1, GRHL2, POU4F1, FOSB, CCNT2, ARID4A, ETS1, HOXA10, LMO2, C5AR1, HMGA1, NFKB1, NFKB2, COPS5, MAFB, FEV, MAFF, ARRB1, ARRB2, MYBL1, MYOCD, KLF13, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPA, CEBPB, CEBPD, CEBPE, TAF9, LEF1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF6, KLF5, POU2AF1, TAF5, RBMX]
GO:0048711;positive regulation of astrocyte differentiation;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;472.09912929902924;7.069023426578259;0.015800732996006494;0.7767511986393403;[BMP2, IL1B, LIF]
GO:0043149;stress fiber assembly;8.0;1.0;0.875;9.628524252492122;75.13737719114397;7.292166977892469;0.00251478039533833;0.747921758369865;[ITGB5, ZYX, ARRB1, SORBS1]
GO:0032526;response to retinoic acid;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;43.78950961223322;5.123113277522946;0.0014655954787213788;0.5522372631225753;[YAP1, TNC, PHB2, AQP1, RXRA, MYB, CTSH, HOXA2, CD38, IGFBP7, LYN, ABCA1, PDGFRB, DUSP1, TIE1, KLF4, PAX2, COL1A1, RARA, EPHA3]
GO:0035914;skeletal muscle cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.845247994956144;7.050676185779127E-4;0.5489262542938873;[BTG2, EOMES, EGR1, MEF2C, EGR2, PAX5, FOS, KLF5, MAFF, ATF3]
GO:0071850;mitotic cell cycle arrest;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;120.3495477317274;7.069023426578259;0.00402799105501988;0.7124295520356204;[CDKN1A, FAP, DUSP1]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, ARRB1, ARRB2, AQP1, LAMP3, RPS6KA1, AKT1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, BIRC3, LEF1, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4, FABP1, VIL1, CD27]
GO:0002439;chronic inflammatory response to antigenic stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;42.97336350789415;8.390779266560578;0.0014382798030929574;0.7522251544931926;[IL1RN, IL1B, TNF]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, CLU, PYCARD, IFIH1, CD36, CCR2, HAVCR2, FCER1G, DDX58, CYBB, MIF, TLR1, IL23A, TLR4, TLR2, PTAFR, LY96, TWIST1, NOD2, THBS1, RASGRP1, CCL19, CD14, FZD5, CARD9, AZU1, CD2, PF4]
GO:0051447;negative regulation of meiotic cell cycle;6.0;0.6696747006330769;0.657957662906683;8.659123695304018;99.47825147867721;6.8867018697843045;0.0033294475523774256;0.6753065664753021;[DUSP1, LIF, BRCA2, MSH2, FBXO5, PRKACB]
GO:0034260;negative regulation of GTPase activity;6.0;1.0;0.8231203125901445;9.628524252492122;61.14468506277762;5.970411137910149;0.0020464575824072424;0.6284474158353811;[LRRK2, ARRB1, ARRB2, F11R, KLRK1, PDE6D, RHOH, GMIP, ADCYAP1]
GO:0071727;cellular response to triacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;168.80270344913424;8.67846133901236;0.005649674571872418;0.8188169164668168;[TLR1, CD14, TLR2]
GO:0035234;ectopic germ cell programmed cell death;5.0;1.0;0.7902410118609202;9.628524252492122;49.330608194382684;7.9853141584524145;0.001651051061600959;0.6986103492792611;[IL1A, IL1B, KIT]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[TNFAIP3, ARRB1, ARRB2, PYCARD, CYP1B1, HAVCR2, IL10, CHUK, IRAK3, SIRT1, NLRC3, PKHD1, NLRP3, NR1H4, KLF4, NFKBIA, NLRP12, CCDC22]
GO:0050805;negative regulation of synaptic transmission;7.0;0.6835726970475526;0.6927057137809769;8.781226392104918;101.84774727695553;5.6339389012889365;0.00340875244433803;0.6390392626740691;[SLC24A2, SLC24A1, ACHE, PLK2, LRRK2, FMR1, GRIK3, PTGS2, GNAI1, GNAI2, IL1B, TNR, CD38, SNCA]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, CD74, EDN1, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL23A, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:0090266;regulation of mitotic cell cycle spindle assembly checkpoint;12.0;0.8653626801206646;0.8808016526504769;9.548481544818586;280.44081179639056;7.138016298065211;0.009386101590480495;0.8131587980249038;[CCNB1, DUSP1, NDC80, MAD2L1]
GO:0060395;SMAD protein signal transduction;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;5.734022359845919;7.75488093814194E-4;0.5834791820027497;[JUN, TGFB2, TGFB1, INHBA, FOS, BMP2, HNF4A]
GO:0010193;response to ozone;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.59609566907567;7.9853141584524145;0.0026640096902085927;0.6986103492792611;[EDN1, IL1B]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[ITGAM, PRKCE, ITGB2, NR1H4, LY96, NFKBIA, S100A14, CD14, TLR4]
GO:0043278;response to morphine;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;93.3430750065417;6.280566066213989;0.0031241087171554015;0.6721078059595746;[ABCB4, PRKCE, TACR3, AIF1, CNR1, IL1B, FOSB]
GO:1900745;positive regulation of p38MAPK cascade;12.0;1.0;0.9481203125901445;9.628524252492122;1761.632567075866;6.7325511899570465;0.05896025665364957;0.7924232935401965;[NCF1, BMP2, IL1B]
GO:0043280;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.811012628672052;0.8536266269261705;9.556203590912496;733.386781063286;4.956792062075433;0.024545795556936395;0.7016108891590862;[FASLG, ARRB1, TNF, CYR61, CTGF, PYCARD, CTSH, SOX7, DAPK1, F2R, SIRT1, F3, IFI27, LCK, S100A9, S100A8, NLRC4, HSPD1, NLRP3, SNCA, CASP8AP2, GSN, TNFRSF10B, HSPE1, PML, NLRP12, P2RX1, DLC1]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[, CDC20, TRIM25, SKP2, CDC34, PLK1, SIRT1, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, PSMC6, NEDD4, PSMC2, MAD2L1, BUB1B, PSMD14, CCNB1, WFS1, UBE2C, CDK1, ARRB1, ARRB2, AURKB, TBX21, RNF24, PML]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[EHMT2, TNC, SESN3, LAMP2, SKP2, POSTN, CYBB, SFRP2, RRAGD, SIK1, ATF3, SEH1L, ABCB4, FOXO1, HMOX1, GAS2L1, LYN, JUN, EIF2AK2, EIF2S1, NR4A2, COL1A1, BCL2, CDKN1A, PLEKHF1, LRRK2, KRT20, ASGR1, UPP1, AVPR1A, FOS, SIRT1, AES, PTGS2, AIF1, FYN, NR1H4, SIPA1, FOXA3, FOXA2]
GO:0032757;positive regulation of interleukin-8 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.948432231191374;0.002183412136085803;0.6273234135236593;[FCN1, SERPINE1, NOD2, TNF, PYCARD, FFAR2, CD58, CD14, ELANE, DDX58, F2R, TLR1, CD2, IL1B, TLR8, TLR7, TLR5, TLR4, CD244, TLR2]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, C3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, PIK3CD, ARRB1, ARRB2, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, IKZF1, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, ACTG2, EOMES, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, NAT8, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, CREB5, TAF9, TBX21, RBM38, EGF, MAPK14, CD4, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, UPF3B, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, RARA, PLCB1, ENG, NR1I2, FAM129A, EPCAM, GSN, NR1H2, NR1H4, GTF2H1, POU4F1, PLP1, FOSB, PF4, CSF3, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DAB2, COPS5, MAFB, MAFF, BCL3, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, SP100, CDX2, CDX1, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, KLF13, CKAP2, AXIN2, DCN, DNM2, IFNG, LEF1, DLL1, THBS1, LUM, MEIS2, MEIS1, RBMX]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, CD14, LYN, TGFB1, PRKCE, IL18, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0032870;cellular response to hormone stimulus;5.0;0.6039883530135606;0.5922351883677006;7.932074963068391;80.94247679971589;3.9540277321974506;0.0027090718549867714;0.49245017396659174;[CYFIP1, PID1, TNC, AQP1, RUVBL2, AKT1, PRKACB, JUNB, PTGDR, MEN1, GHSR, MED1, LHCGR, MEF2C, PRKCE, PRKCD, LMO2, ADCYAP1, POR, ADCY9, RAB31, PRKAR1B, SIK1, FECH, ABCB4, SLC30A10, GATA1, FOXO1, SOCS2, PRKAR2B, IGFBP7, GAS2L1, JUN, TGFB1, CAV1, CDC6, INHBA, NFKB1, NR4A2, NR4A1, KIF18A, NR4A3, FBN1, ROBO2, CTSS, GHR, CTSH, CTSB, IL10, EDN1, ANXA1, DUSP1, ARG1, GLP2R, AVPR1A, FOS, CCNA2, CEACAM1, KIT, PTGER2, AIF1, P2RY6, PAK1, SPP1, FYN, CSK, SORBS1, POU4F1, TSHR, FOSB, RAMP1]
GO:0030213;hyaluronan biosynthetic process;8.0;1.0;0.875;9.628524252492122;506.6998597758615;7.8311634786251565;0.01695878830643033;0.7754860644832351;[IL1B]
GO:0071726;cellular response to diacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;168.80270344913424;8.390779266560578;0.005649674571872418;0.8041048419030481;[CD36, TLR6, CD14, TLR2]
GO:0071639;positive regulation of monocyte chemotactic protein-1 production;7.0;1.0;0.8509193652572005;9.628524252492122;88.62106486279957;7.474488534686424;0.0029660672871775788;0.7331650565203278;[IL1A, IL1B, TWIST1]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[TGFB1, ABCB4, TNC, PTGS2, CXCL10, CD4, IL1B, SPP1, ALPL, TRIM25]
GO:0051591;response to cAMP;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;79.54904468548885;5.192106149009898;0.0026624349361310785;0.5886448625081389;[SPARC, PTAFR, AQP9, SLC8A1, AQP1, THBD, JUNB, JUN, IGFBP5, DUSP1, FOS, NME1, COL1A1, KCNQ1, NDUFS4, NOX4, SDC1, MMP19, FOSB, TEK, SLC26A3, CFTR]
GO:0010718;positive regulation of epithelial to mesenchymal transition;6.0;0.811012628672052;0.7286266269261705;9.377209824211215;170.70262580884207;5.9928839937622085;0.005713263263432726;0.6295966787287501;[TGFB1I1, LEF1, TWIST1, LOXL2, EPB41L5, PDPN, TGFB2, TGFB1, AXIN2, COL1A1, BMP2, DAB2, IL1B, EZH2, ENG]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, RARA, ASCL2, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, CEBPA, CEBPB, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, EDN1, PARP9, IL1B, SP100, SATB2, RXRA, CDX2, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[CSF3, SPI1, SPARC, TNC, EEF1B2, ALAD, PRKCE, CYBB, ADCYAP1, CLDN3, IL1B, CLDN7, RARA, S100A8, PSMD14, FECH, GATA3, CCL7, CNR1, FYN, CD14, GSN, VCAM1, CDK1, CD27]
GO:0010955;negative regulation of protein processing;9.0;0.7192862368539868;0.7558837436072825;9.27570287786938;707.1969765737138;6.039404009397101;0.023669246369964203;0.705096027081865;[LRRK2, CTSZ, SERPINE1, NLRC4, THBS1, A2M, CR1, IL1R2, GAS1, BIRC5, SERPING1, NAIP, BIRC3]
GO:0060071;Wnt signaling pathway, planar cell polarity pathway;9.0;0.7436939687323844;0.7680876095464813;9.094441766561864;99.0414819593438;5.825829909099042;0.0033148292696323837;0.694173837660411;[ARRB2, CELSR1, AP2M1, CTHRC1, FZD1, FZD5, VANGL1, SFRP2, PFN1]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[PTPRR, PTPN22, PTPRK, DUSP10, DUSP2, DUSP3, DUSP1, DUSP6, CDC25A, TPTE, PTPRE, PTPRC, PTPN6, PTPN7, PTPN4]
GO:2000573;positive regulation of DNA biosynthetic process;8.0;0.7980440201809971;0.7740220100904985;9.427853557029971;748.2879117532506;5.618190544320798;0.02504452299098255;0.6623145257091445;[ARRB2, AURKB, CCT8, CCT7, CCT5, CCT4, RFC5, PDGFRB, CCT3, CCT2, RFC3, RFC4, RFC2, KLF4, GRHL2, CCT6A, GREM1, NOX4, PRKCQ]
GO:0034128;negative regulation of MyD88-independent toll-like receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.8311634786251565;0.011871713162238609;0.7967266896635242;[LY96, CD14, TLR4]
GO:0034122;negative regulation of toll-like receptor signaling pathway;8.0;0.7140352122741334;0.7320176061370667;9.0094850440859;260.8137256220838;6.166155715036245;0.00872920067945721;0.6903374900225189;[LYN, LY96, TNFAIP3, IRAK3, ARRB2, LILRA2, TLR6, CD14, TLR4, LGR4]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[SPI1, TFRC, FMR1, TNF, ETS1, SLC8A1, AQP1, IL18RAP, CDH1, MYB, CYP1B1, KCNH2, MEF2C, PRKCE, PRKCD, CYBB, KCNQ1, CFTR, BLM, FECH, ABCB4, FOXO1, PDGFD, HMOX1, ECT2, EGR1, TGFB1, JUP, NFKB1, IL6, ID1, CDK1, EZH2, LRRK2, TNFAIP3, PTPN22, BRCA1, PDE4B, MAP4K1, EDN1, ANXA1, PPP1R12A, ARG1, CAD, SIRT1, PAX2, DNM2, NME1, CCNA2, IL1B, FBP1, PCNA, PTAFR, NOD2, PTGS2, AIF1, GNAI1, CST3, CCL7, CTNNA1, FYN, KLF4, MAPK13, FABP1, RAD51, CD69]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[IL1RN, ADM, PRL, ETS1, THBD, CD38, TGFB1, IGFBP5, CAD, FOS, ADCYAP1, CLDN4, PNOC, RARA, BCL2, FOSB]
GO:0007202;activation of phospholipase C activity;9.0;1.0;0.896240625180289;9.628524252492122;83.73920694944017;6.444869117505266;0.0028026758962043192;0.7258315315665724;[ITK, TXK, C5AR1, AVPR1A, SELE, RASGRP4, EDNRA, GNA15, GNAQ, PLCG1]
GO:0090240;positive regulation of histone H4 acetylation;12.0;0.9326813400603323;0.9144609826203107;9.60254876608886;1488.9056195780981;7.8311634786251565;0.04983233115921682;0.8486063770733797;[ARRB1, BRCA1]
GO:0046329;negative regulation of JNK cascade;12.0;0.9326813400603323;0.9144609826203107;9.607904965289386;1764.4523437695266;6.280566066213989;0.05905463204195212;0.7693087532925187;[DUSP3, PTPN22, DUSP10, SFRP2, AKT1, ZMYND11, MEN1]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRA, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, PDGFRA, PRKCE, F2R, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, ITPR3, FPR2, THY1, CD19, HRH4, PLCG1, CCR10, CCR1, CAV1, CXCL10, CXCL11, PTPRC, CALM3, CD24, GPR18, CXCL9, FASLG, ADM, JPH2, CCR9, CD38, CCR7, CCR6, CD36, CCR5, CCR2, CD52, PTGIR, EDN1, TRPC3, GPR35, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, GNA15, CXCR1, CXCR3, CXCR2, S1PR3, CCL1, CCL19, GPR157, SNCA, CCL21, GPR6, P2RX5, CD4, FKBP1B, F2RL3]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, RARA, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, TNFRSF1B, ADAMTS20, BIRC5, BIRC3, CX3CR1, CEBPB, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, IL1RN, SLC46A2, IFIT3, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, TEK, NAA15]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, NOX1, ADM, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A9, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, BCL2, BCL2L1, PLEKHF1, PIK3CD, FASLG, ARRB1, ARRB2, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, GZMA, GZMB, PML, P2RX1, MNDA, IFIT2, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, TNFAIP8, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0034116;positive regulation of heterotypic cell-cell adhesion;6.0;1.0;0.8231203125901445;9.628524252492122;52.08961109106789;7.212124270218933;0.001743392405611612;0.6919486831672181;[IL10, CEACAM6, IL1B, THY1, TNF]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[NCF2, ITGB3, NCF4, ICAM3, ITGAL, CD36, ANXA1, CD93, ANXA3, SLC11A1, DNM2, PECAM1, RARA, PRTN3, CD302, LRP1, CEBPE, PLD4, CORO1A, CD14, ELANE, SLAMF1, MARCO]
